Evidence map›Paper›PMID 41000732›Full record

ArticlebioRxiv : the preprint server for biology2025

Microcystin-LR aerosol exposure increases inflammatory drivers of asthma, Evidence of an NF-κB amplification mechanism.

Joshua D Breidenbach, Bivek Timalsina, Benjamin W French, Lauren Stanoszek, John-Paul Lavik, Irum S Breidenbach, Upasana Shrestha, Andrew Kleinhenz, Apurva Lad, Prabhatchandra Dube and 10 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Joshua D BreidenbachCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-5892-1879
Bivek TimalsinaCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0003-0734-0780
Benjamin W FrenchCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-7861-6740
Lauren StanoszekCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0001-9159-6011
John-Paul LavikDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.ORCID 0000-0003-4697-4735
Irum S BreidenbachCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-0879-3450
Upasana ShresthaCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0009-0004-2938-1270
Andrew KleinhenzCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-7088-0088
Apurva LadCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0001-6073-7432
Prabhatchandra DubeCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0003-2163-5788
Shungang ZhangCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-6668-7453
Dhilhani FaleelCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0003-3234-8688
R Mark WootenCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0003-1156-3485
James C WilleyCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-1192-6824
Jeffrey R HammersleyCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-8550-2717
Nikolai N ModyanovCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0003-1889-4965
Deepak MalhotraCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-0934-1560
Lance D DworkinCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-2471-5989
Steven T HallerCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.ORCID 0000-0002-6919-6342
David J KennedyCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.

Funding

The synergistic effects of climate and anthropogenic drivers on toxic cyanobacterial bloomsP01ES028939 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Gregory James Dick · 2018 to 2026
$3.7M
Counter regulatory mechanisms of cardiotonic steroids in cardio-renal syndromeR01HL137004 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KENNEDY, DAVID JOSEPH · 2017 to 2021
$1.9M
Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic InflammationF31HL160178 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI BREIDENBACH, JOSHUA DAVID · 2021 to 2022
$60k
NHLBI NIH HHS F31 HL160178NHLBI NIH HHS R01 HL137004NIEHS NIH HHS P01 ES028939
6 · The paper itself

Abstract

Microcystin-LR (MC-LR) is one of a large family of cyanotoxins which are naturally produced by cyanobacteria within harmful algal blooms occurring in bodies of water globally. Early findings of the toxicity of such blooms stemmed from fatalities of livestock drinking from affected water. Since then, various toxins have been identified such as the microcystins. Microcystin-LR has been studied as a representative congener due to its abundance and toxicity. While there have been extensive studies of microcystin-LR by oral route exposure, we have turned our attention to inhalation route exposure due to the recent findings of microcystin-containing lake and sea-spray aerosol. We have shown inflammatory outcomes in the airways of mice and in human cell culture models after microcystin aerosol exposure, and have found a consistent molecular patterns similar to those of Type 1/Type 17 driven neutrophilic asthma. Here we address the hypothesis that MC-LR will increase the inflammatory mediators of neutrophilic asthma leading to worsening symptoms. This is tested and characterized in both

Identifiers

PMID41000732
PMCPMC12458923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.